Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-03 · accession 0001765581-22-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 | 2022-03-03 | JAZZ | Iannone Robert | EVP, Gbl Head of R, D, Ch | A - Grant | $0.00 | +11.4K | 40.6K | +39% | $0 | |
| 2022-03-09 | 2022-03-05 | JAZZ | Iannone Robert | EVP, Gbl Head of R, D, Ch | F - Tax | $153.96 | -1,327 | 39.3K | -3% | -$204.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-03 | A | A | 11,374 | $0.00 | 40,584 | D | — | — | (F2) Includes 124 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2021. |
| 2 | Common | Ordinary Shares | 2022-03-05 | F | D | 1,327 | $153.96 | 39,257 | D | — | — |